Clinical Trials Browser

Terminated × OTHER × HM781-36B × Clear all

NCT03066206 2026-02-20

Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT01819428 2016-03-01

NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma

Phase 2 Terminated

Adenocarcinoma of Lung